Par Drugs and Chemicals Limited — Others, 13-02-2025: Shareholders meeting

PAR Drugs and Chemicals has submitted the Scrutinizer's report following its Extra Ordinary General Meeting (EGM). The meeting confirmed the approval of two significant resolutions: the slump sale of the existing establishment, with a total of 582,314 votes (77.83% in favor), and a venture into real estate and renewable energy businesses, supported by 582,338 votes (78.83% in favor). This approval facilitates strategic diversification in the company’s operations, potentially enhancing its revenue streams. For investors, this development may signal a positive outlook, indicating management's proactive approach to growth and adaptation in evolving market conditions.